Adial Pharmaceuticals Inc (ADIL)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.9701
-0.04
(-3.95%)
After-Hours: 04:23
Adial Pharmaceuticals Shareholders Equity (Quarterly): 4.277M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.277M |
| March 31, 2024 | 6.122M |
| December 31, 2023 | 4.084M |
| September 30, 2023 | 2.339M |
| June 30, 2023 | 3.317M |
| March 31, 2023 | 1.440M |
| December 31, 2022 | 3.276M |
| September 30, 2022 | 5.409M |
| June 30, 2022 | 7.961M |
| March 31, 2022 | 10.71M |
| December 31, 2021 | 3.508M |
| September 30, 2021 | 7.200M |
| June 30, 2021 | 4.829M |
| March 31, 2021 | 5.618M |
| December 31, 2020 | 3.986M |
| Date | Value |
|---|---|
| September 30, 2020 | 7.085M |
| June 30, 2020 | 8.793M |
| March 31, 2020 | 5.551M |
| December 31, 2019 | 7.141M |
| September 30, 2019 | 8.73M |
| June 30, 2019 | 10.06M |
| March 31, 2019 | 11.73M |
| December 31, 2018 | 4.441M |
| September 30, 2018 | 4.929M |
| June 30, 2018 | -1.294M |
| March 31, 2018 | -1.307M |
| December 31, 2017 | -0.9976M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | -0.1035M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.440M
Minimum
Mar 2023
10.71M
Maximum
Mar 2022
5.402M
Average
5.409M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.949M |
| Total Liabilities (Quarterly) | 0.6719M |